Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China
· Delayed Price · Currency is CNY 11.72
-0.01 (-0.09%)
Jun 23, 2025, 11:29 AM CST
SHA:603439 Market Cap
SHA:603439 has a market cap or net worth of 4.71 billion as of June 20, 2025. Its market cap has decreased by -24.52% in one year.
Market Cap
4.71B
Enterprise Value
5.11B
Revenue
2.13B
Ranking
n/a
PE Ratio
18.67
Stock Price
11.72
Market Cap Chart
Since April 28, 2020, SHA:603439's market cap has increased from 4.31B to 4.71B, an increase of 9.40%. That is a compound annual growth rate of 1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 4.71B | -9.42% |
| Dec 31, 2024 | 5.20B | -32.74% |
| Dec 29, 2023 | 7.74B | 37.27% |
| Dec 30, 2022 | 5.64B | -13.05% |
| Dec 31, 2021 | 6.48B | -21.44% |
| Dec 31, 2020 | 8.25B | 91.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 343.26B |
| Shenzhen Mindray Bio-Medical Electronics | 274.85B |
| WuXi AppTec | 187.01B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.66B |
| Sichuan Biokin Pharmaceutical | 117.45B |
| Aier Eye Hospital Group | 110.25B |
| Shanghai United Imaging Healthcare | 105.34B |
| Yunnan Baiyao Group Co.,Ltd | 98.19B |